Skip to main content
BIOME AUSTRALIA LIMITED logo

BIOME AUSTRALIA LIMITED — Investor Relations & Filings

Ticker · BIO ISIN · AU0000184137 ASX Manufacturing
Open in API
Filings indexed 303 across all filing types
Latest filing 2024-11-20 Director's Dealing
Country AU Australia
Listing ASX BIO

About BIOME AUSTRALIA LIMITED

https://www.biomeaustralia.com

Biome Australia Limited is a microbiome health company specializing in the development and distribution of evidence-based probiotics and complementary medicines. The company focuses on translating microbiome science into accessible healthcare solutions through its flagship brand, Activated Probiotics. Its product portfolio consists of condition-specific formulations designed to address various health areas, including digestive health, immune system support, bone density, and mental wellbeing via psychobiotics. Biome Australia prioritizes clinical research and collaborates with global experts to ensure the efficacy of its formulations. The company’s distribution strategy centers on a network of community pharmacies and independent health practitioners, providing professional-grade supplements to the retail and clinical markets.

Recent filings

Filing Released Lang Actions
Initial Director's Interest Notice 2 pages 251.7KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3X Initial Director’s Interest Notice' and references ASX listing rule 3.19A.1 and section 205G of the Corporations Act. It details the appointment of a director and the director's relevant interests in securities, including shares held directly and indirectly. The content focuses on disclosure of personal shareholdings by a company director, which aligns with insider trading or director dealing reports. The document length is 2440 characters, which is consistent with a short notice rather than a full report. Therefore, this document fits the category of Director's Dealing (DIRS).
2024-11-20 English
Results of Annual General Meeting 2 pages 288.9KB
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is an ASX announcement dated 19 November 2024, titled 'Results of Annual General Meeting'. It provides detailed voting results for resolutions passed at the AGM, including adoption of remuneration report, re-election of director, ratification of prior issue of options, renewal of shareholder approval of employee incentive plan, and approval of a mandate. The document references compliance with Listing Rule 3.13.2 and Section 251AA of the Corporations Act, which relate to disclosure of voting results. The content is focused on the official results of shareholder votes at the AGM, not the AGM materials or the full annual report. The document length is 4075 characters, which is relatively short and consistent with a voting results announcement rather than a full report. Therefore, the document fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2024-11-18 English
Company Presentation 22 pages 14.6MB
Investor Presentation Classification · 100% confidence The document is titled as a "Company Presentation" dated November 2024 and contains detailed information about Biome Australia's business strategy, product offerings, market expansion plans, sales highlights, and financial summary figures. It includes forward-looking statements, strategic plans, market development, and product pipeline details. There is no indication that this is a formal regulatory filing such as an annual or interim report, audit report, or earnings release. The document is clearly a presentation aimed at investors or stakeholders to communicate company strategy, financial highlights, and growth plans. This matches the definition of an Investor Presentation (IP). The document length is substantial (over 14,000 characters) and contains substantive content rather than just an announcement or a brief summary, so it is not a Report Publication Announcement or Regulatory Filing. Therefore, the appropriate classification is Investor Presentation (IP).
2024-11-17 English
Biome Strain Development Program Success 4 pages 284.8KB
Regulatory Filings Classification · 95% confidence The document is an ASX announcement dated 14 November 2024, providing an update on the successful development and commercial validation of a probiotic strain by Biome Australia Limited. It discusses intellectual property transfer, research and development plans, and commercial implications. The content is a corporate update on a specific business development rather than a financial report, regulatory filing, or meeting material. It does not contain financial statements, voting results, or executive changes. The document is a typical corporate announcement about a business milestone and intellectual property progress, which fits best under the category of a general regulatory announcement. Therefore, the most appropriate classification is Regulatory Filings (RNS).
2024-11-13 English
Business and International Market Update 4 pages 265.4KB
Capital/Financing Update Classification · 90% confidence The document is an ASX announcement dated 13 November 2024 providing a business and international market update for Biome Australia Limited. It discusses recent market launches, product approvals, sales performance, and strategic plans. There are no detailed financial statements, quarterly or annual results, or audit information presented. The content is focused on operational updates and market expansion rather than financial results or governance changes. The document length is 8106 characters, which is substantial but the content is clearly an update rather than a full financial report or earnings release. It does not fit categories like Annual Report (10-K), Interim Report (IR), Earnings Release (ER), or Management Reports (MDA). It is not a regulatory filing or certification. The best fitting category is Capital/Financing Update (CAP) as it relates to business and market updates including product launches and sales growth, which are typical of capital and financing related announcements to investors.
2024-11-12 English
Quarterly Activities & Cashflow Report 14 pages 1.1MB
Interim / Quarterly Report Classification · 100% confidence The document is an ASX announcement dated 24 October 2024, titled 'Quarterly Activities & Appendix 4C September 2024'. It provides detailed financial and operational data for the quarter ended 30 September 2024, including EBITDA, cash receipts, sales revenue, cash flow statements, and commentary on business activities. The presence of Appendix 4C, which is a quarterly cash flow report required by ASX Listing Rule 4.7B, confirms this is a quarterly report. The document contains substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. It is not merely an announcement of a report or a certification, but a comprehensive quarterly financial and operational update. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q1 2025
2024-10-23 English

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.